JP2023515572A5 - - Google Patents
Info
- Publication number
- JP2023515572A5 JP2023515572A5 JP2022551283A JP2022551283A JP2023515572A5 JP 2023515572 A5 JP2023515572 A5 JP 2023515572A5 JP 2022551283 A JP2022551283 A JP 2022551283A JP 2022551283 A JP2022551283 A JP 2022551283A JP 2023515572 A5 JP2023515572 A5 JP 2023515572A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutically acceptable
- addition salts
- optical isomers
- acceptable bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305207.1 | 2020-02-28 | ||
| EP20305207 | 2020-02-28 | ||
| PCT/EP2021/054780 WO2021170774A1 (en) | 2020-02-28 | 2021-02-26 | New macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515572A JP2023515572A (ja) | 2023-04-13 |
| JP2023515572A5 true JP2023515572A5 (https=) | 2024-03-04 |
| JP7757298B2 JP7757298B2 (ja) | 2025-10-21 |
Family
ID=70977485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551283A Active JP7757298B2 (ja) | 2020-02-28 | 2021-02-26 | 新規な大環状化合物、それを製造するための方法及びそれを含有する医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230097678A1 (https=) |
| EP (1) | EP4110776A1 (https=) |
| JP (1) | JP7757298B2 (https=) |
| KR (1) | KR20220148851A (https=) |
| CN (1) | CN115151538B (https=) |
| AR (1) | AR121435A1 (https=) |
| AU (1) | AU2021226994A1 (https=) |
| BR (1) | BR112022016286A2 (https=) |
| IL (1) | IL295595B1 (https=) |
| MX (1) | MX2022010673A (https=) |
| TW (1) | TWI891735B (https=) |
| WO (1) | WO2021170774A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021014680A (es) | 2019-05-31 | 2022-04-06 | Ube Corp | Derivado de benzotriazol. |
| CN114028374A (zh) * | 2021-12-01 | 2022-02-11 | 江苏省人民医院（南京医科大学第一附属医院） | 富马酸二甲酯在制备用于保护胰岛β细胞功能的药物中的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102301867B1 (ko) * | 2013-12-18 | 2021-09-15 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
-
2021
- 2021-02-26 EP EP21707266.9A patent/EP4110776A1/en active Pending
- 2021-02-26 JP JP2022551283A patent/JP7757298B2/ja active Active
- 2021-02-26 BR BR112022016286A patent/BR112022016286A2/pt unknown
- 2021-02-26 TW TW110106890A patent/TWI891735B/zh active
- 2021-02-26 KR KR1020227032838A patent/KR20220148851A/ko active Pending
- 2021-02-26 WO PCT/EP2021/054780 patent/WO2021170774A1/en not_active Ceased
- 2021-02-26 AU AU2021226994A patent/AU2021226994A1/en active Pending
- 2021-02-26 IL IL295595A patent/IL295595B1/en unknown
- 2021-02-26 AR ARP210100493A patent/AR121435A1/es unknown
- 2021-02-26 US US17/904,514 patent/US20230097678A1/en active Pending
- 2021-02-26 CN CN202180016377.4A patent/CN115151538B/zh active Active
- 2021-02-26 MX MX2022010673A patent/MX2022010673A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6305344B2 (ja) | 活性作用物質の送達のための生分解性脂質 | |
| JP7297676B2 (ja) | 新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤 | |
| JP7387745B2 (ja) | 活性物質の送達のための生分解性脂質 | |
| JP2024518554A5 (https=) | ||
| JP2024105360A5 (https=) | ||
| WO2012162210A1 (en) | Ring constrained cationic lipids for oligonucleotide delivery | |
| EP2581376A1 (en) | Matrinic acid/ matrine derivatives and preparation methods and uses thereof | |
| JP2006512301A5 (https=) | ||
| FR2957079A1 (fr) | Procede de synthese de derives de cetobenzofurane | |
| HUP0204147A2 (hu) | [(RR,SS)-3-(2-dimetilaminoetil-1-hidroxiciklohexil)fenil]-2-hidroxibenzoátból származtatott új észterek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| JP2023515572A5 (https=) | ||
| JP2023002701A5 (https=) | ||
| CN112930214A (zh) | 含氘化合物 | |
| EP1140807B1 (fr) | Procede de preparation de nitroxydes | |
| AU754317B2 (en) | Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same | |
| RU2003134629A (ru) | Соединения цефема | |
| AU2024242063A1 (en) | Cyp11a1 inhibitor and use thereof | |
| WO2014138460A1 (en) | 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors | |
| JP2004529172A5 (https=) | ||
| EP0087378B1 (fr) | Ethers-oximes d'alcoylaminoalcools comme médicaments, produits nouveaux et procédés pour leur préparation | |
| IL295595A (en) | New macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
| RU2343157C2 (ru) | Аналоги колхикозида | |
| CA2551501A1 (en) | Tolterodine, compositions and uses thereof, and preparation of the same | |
| LU81554A1 (de) | Alkylthiophenoxyalkylamines | |
| CN111777638A (zh) | 喹啉类化合物、其制备方法、药物组合物和用途 |